Rajesh Kamalakar

Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study

Jacqueline S. Garcia, Andrew H. Wei, Uma Borate et al. · Blood · 2020 · 58 citations

Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance

David S. Goldberg, Adriana Valderrama, Rajesh Kamalakar et al. · Journal of Clinical Gastroenterology · 2015 · 44 citations

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

Keith W. Pratz, Panayiotis Panayiotidis, Christian Récher et al. · Blood Cancer Journal · 2022 · 32 citations · Full text

Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B

David S. Goldberg, Adriana Valderrama, Rajesh Kamalakar et al. · Journal of Viral Hepatitis · 2015 · 30 citations · Full text

Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.

Todd Williamson, Rajesh Kamalakar, Augustina Ogbonnaya et al. · PubMed · 2017 · 13 citations